AXIM Biotechnologies, Inc. (OTCMKTS:AXIM – Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totaling 90,412 shares, a growth of 373.7% from the August 31st total of 19,085 shares. Based on an average trading volume of 566,486 shares, the days-to-cover ratio is currently 0.2 days.
AXIM Biotechnologies Price Performance
AXIM stock opened at $0.00 on Friday. AXIM Biotechnologies has a 12 month low of $0.00 and a 12 month high of $0.03.
About AXIM Biotechnologies
AXIM Biotechnologies, Inc is a biotechnology company focused primarily on diagnostic technologies, with an emphasis on ophthalmology and diseases that can be identified through biomarkers in tears. The company has developed diagnostic platforms intended to support the detection and monitoring of conditions such as dry eye disease.
AXIM’s ophthalmic development programs have included rapid, point-of-care tests designed to measure biomarkers associated with inflammation and other ocular conditions.
See Also
- Five stocks we like better than AXIM Biotechnologies
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for AXIM Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIM Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
